Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Cash from Financing Activities (2021 - 2026)

MoonLake Immunotherapeutics' Cash from Financing Activities history spans 6 years, with the latest figure at $30.6 million for Q1 2026.

  • Quarterly Cash from Financing Activities fell 58.09% to $30.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $103.5 million through Mar 2026, up 40.93% year-over-year, with the annual reading at $146.0 million for FY2025, 184.53% up from the prior year.
  • Cash from Financing Activities came in at $30.6 million for Q1 2026, down from $72.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $451.3 million in Q2 2023 to a low of $3791.0 in Q4 2022.
  • The 5-year median for Cash from Financing Activities is $29.5 million (2023), against an average of $68.9 million.
  • Year-over-year, Cash from Financing Activities crashed 99.99% in 2022 and then soared 749462.31% in 2023.
  • MoonLake Immunotherapeutics' Cash from Financing Activities stood at $3791.0 in 2022, then skyrocketed by 749462.31% to $28.4 million in 2023, then crashed by 99.47% to $151000.0 in 2024, then surged by 47843.71% to $72.4 million in 2025, then plummeted by 57.67% to $30.6 million in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Cash from Financing Activities are $30.6 million (Q1 2026), $72.4 million (Q4 2025), and $480000.0 (Q3 2025).